Development and Pilot Study of Primary Care Loneliness Interventions to Prevent Suicide

预防自杀的初级保健孤独干预措施的开发和试点研究

基本信息

项目摘要

Project Summary/Abstract Suicide is a leading cause of death in the US with an estimated 46,000 suicide deaths occuring in 2020. Loneliness, an interpersonal risk factor for suicide, was recognized as having reached epidemic proportions by the US Surgeon General in 2017 before rates further worsened due to the COVID-19 pandemic. Given the public health impact of loneliness, the National Academies of Engineering, Sciences, and Medicine have called for health systems to take an active role and intervene to reduce loneliness. Primary care is the optimal health system setting to deliver loneliness interventions to prevent suicide because primary care increasingly screens for loneliness along with other social determinants of health. Primary care practices also increasingly employ behavioral health care managers who can deliver loneliness interventions along with treatments for depression and anxiety disorders that may impair recovery from chronic loneliness and contribute to suicide risk. Prior primary care approaches to loneliness have had mixed results and there remains no established, effective, ready-to-adopt model to reduce loneliness and suicidal ideation in primary care. This study will adapt two loneliness interventions, social prescribing and brief cognitive therapy, to be delivered within primary care. Social prescribing addresses the structural determinants of loneliness (i.e., breadth and frequency of social interactions) by linking patients to community-based organizations or activities (e.g., volunteering) whereas brief cognitive therapy addresses the cognitive determinants of loneliness (i.e., relationship expectations) through education, reflections, and guided exercises. In contrast to prior studies, both interventions will be adapted to be delivered by a behavioral health care manager working within a primary care-based collaborative care management program. The specific aims of the project are: 1) Adapt social prescribing and brief cognitive therapy interventions for loneliness to be delivered as components of primary care collaborative care management and 2) conduct a randomized controlled pilot study (N=60) to determine feasibility and acceptability of the two interventions and trial protocols. The Aim 1 development activities will be guided by the ADAPT-ITT (assessment, decision, administration, production, topical experts, integration, training, testing) framework and will engage patient and provider stakeholders to inform production of manuals to guide training and pilot testing of the interventions. In the Aim 2 pilot study, patients from two primary care sites who screen positive for loneliness and suicidal ideation will be randomly assigned to one of the two interventions or to EUC. At 3 months, participants in the intervention arms will receive the alternate intervention for an additional 3 months, and EUC participants will continue to receive EUC. Feasibility and acceptability will be measured to inform a future adequately powered trial to determine the interventions’ mechanisms and effectiveness for reducing loneliness and suicidal ideation.
项目摘要/摘要 自杀是美国的主要死亡原因,估计在2020年发生了46,000例自杀死亡。 孤独感是自杀的一种人际交往风险因素,被认为已经达到了流行比例 2017年,美国外科医生由于19号大流行而在2017年进一步降低了比率。鉴于 孤独,国家工程学,科学和医学学院对公共卫生的影响 让卫生系统发挥积极作用并干预以减少孤独感。初级保健是最佳健康 进行孤独干预以防止自杀的系统设置,因为初级保健越来越多地筛选 孤独以及其他社会决定者。初级保健实践也越来越多地采用 可以提供孤独干预以及抑郁症治疗的行为医疗保健经理 以及可能会损害慢性孤独感并导致自杀风险的焦虑症。事先的 孤独的初级保健方法的结果好坏参半,没有建立,有效的, 即将添加的模型,以减少初级保健中的孤独和自杀想法。 这项研究将适应两种孤独干预措施,社会处方和简短的认知疗法 在初级保健中。社会处方介绍了孤独的结构决定者(即广度和广度 社交互动的频率)通过将患者与社区组织或活动联系起来(例如, 志愿服务),而简短的认知疗法旨在解决孤独的认知决定者(即 关系期望)通过教育,思考和指导练习。与先前的研究相反, 两种干预措施都将改编成由行为医疗保健经理提供的 基于初级保健的协作护理管理计划。该项目的具体目的是:1)适应 社会处方和简短的认知疗法干预措施,以作为孤独感作为组成部分 初级保健协作护理管理和2)进行随机对照试验研究(n = 60) 确定两种干预措施和试验方案的可行性和可接受性。 AIM 1开发活动将由Adapt-Itt指导(评估,决策,行政管理, 生产,局部专家,集成,培训,测试)框架,并将吸引患者和提供者 利益相关者为制作手册提供指导干预措施的培训和试点测试。目的 2个试点研究,来自两个初级保健网站的患者筛选孤独和自杀想法的阳性 被随机分配给两种干预措施之一或EUC。在三个月时,干预参与者 武器将再进行另外三个月的替代干预,EUC参与者将继续 接收EUC。将衡量可行性和可接受性,以告知将来的充分动力试验 确定干预措施的机制和有效性,以减少孤独和自杀思想。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Paul Nelson Pfeiffer其他文献

Paul Nelson Pfeiffer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Paul Nelson Pfeiffer', 18)}}的其他基金

Effectiveness and Implementation of a Peer Mentorship Intervention (PREVAIL) to Reduce Suicide Attempts Among High-Risk Adults
同伴辅导干预 (PREVAIL) 减少高危成年人自杀企图的有效性和实施
  • 批准号:
    10379598
  • 财政年份:
    2021
  • 资助金额:
    $ 23.4万
  • 项目类别:
Incorporating Treatment Outcomes into Quality Measurement of Depression Care
将治疗结果纳入抑郁症护理的质量衡量
  • 批准号:
    9789661
  • 财政年份:
    2016
  • 资助金额:
    $ 23.4万
  • 项目类别:
Incorporating Treatment Outcomes into Quality Measurement of Depression Care
将治疗结果纳入抑郁症护理的质量衡量
  • 批准号:
    10152358
  • 财政年份:
    2016
  • 资助金额:
    $ 23.4万
  • 项目类别:
Peer mentorship to reduce suicide risk following psychiatric hospitalization
同伴辅导可降低精神病住院后的自杀风险
  • 批准号:
    8678081
  • 财政年份:
    2014
  • 资助金额:
    $ 23.4万
  • 项目类别:
Peer mentorship to reduce suicide risk following psychiatric hospitalization
同伴辅导可降低精神病住院后的自杀风险
  • 批准号:
    8890240
  • 财政年份:
    2014
  • 资助金额:
    $ 23.4万
  • 项目类别:

相似国自然基金

基于腔光机械效应的石墨烯光纤加速度计研究
  • 批准号:
    62305039
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于自持相干放大的高精度微腔光力加速度计研究
  • 批准号:
    52305621
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
位移、加速度双控式自复位支撑-高层钢框架结构的抗震设计方法及韧性评估研究
  • 批准号:
    52308484
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
高离心加速度行星排滚针轴承多场耦合特性与保持架断裂失效机理研究
  • 批准号:
    52305047
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
基于偏心光纤包层光栅的矢量振动加速度传感技术研究
  • 批准号:
    62305269
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Unified, Scalable, and Reproducible Neurostatistical Software
统一、可扩展且可重复的神经统计软件
  • 批准号:
    10725500
  • 财政年份:
    2023
  • 资助金额:
    $ 23.4万
  • 项目类别:
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)
明尼苏达大学临床与转化科学研究所 (UMN CTSI)
  • 批准号:
    10763967
  • 财政年份:
    2023
  • 资助金额:
    $ 23.4万
  • 项目类别:
BiOengineering Research Education to AcceLerate Innovation in STEM
生物工程研究教育加速 STEM 创新
  • 批准号:
    10652133
  • 财政年份:
    2023
  • 资助金额:
    $ 23.4万
  • 项目类别:
Neurosurgeon Research Career Development Program (NRCDP)
神经外科医生研究职业发展计划 (NRCDP)
  • 批准号:
    10541698
  • 财政年份:
    2023
  • 资助金额:
    $ 23.4万
  • 项目类别:
TMJ SYMPHONY Systems-integrated model and mechanisms of patient-centered holistic outcomes and network-supported training and therapy
TMJ SYMPHONY 系统集成模型和以患者为中心的整体结果机制以及网络支持的培训和治疗
  • 批准号:
    10829112
  • 财政年份:
    2023
  • 资助金额:
    $ 23.4万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了